Leaflet TALIDOMIDA ACCORD 50mg capsules

Indicated for: cancer

Route of administration: oral

Substance: thalidomide (immunomodulator)

ATC: L04AX02 (Antineoplastic and immunomodulating agents | Immunosuppressants | Other immunosuppressants)

Precautions:
Contraception required
Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding
Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Avoid live vaccines
Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk
Immunosuppression / infection risk

This medicine may increase the risk of infections.

Teratogenic / fetal risk
Teratogenic / fetal risk

This medicine may affect fetal development.

Thalidomide is a medication currently used to treat certain conditions such as multiple myeloma, erythema nodosum leprosum (a complication of leprosy), and other inflammatory or autoimmune diseases. It is known for its immunomodulatory, anti-inflammatory, and antiangiogenic properties, making it useful in controlling inflammation and tumor growth.

How it works: Thalidomide inhibits the production of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), and reduces the formation of new blood vessels (angiogenesis), which limits tumor growth.

Main indications:

- Multiple myeloma: Used in combination with other drugs to slow disease progression.
- Erythema nodosum leprosum: Helps reduce inflammation and associated symptoms.
- Autoimmune diseases: In some cases, it is used off-label for conditions like systemic lupus erythematosus or Crohn's disease.

Side effects: Thalidomide may cause drowsiness, constipation, peripheral neuropathy (numbness or tingling in the hands and feet), dizziness, and skin rashes. In rare cases, it can increase the risk of blood clots.

Special warnings: Thalidomide is highly teratogenic, meaning it can cause severe birth defects if taken during pregnancy. For this reason, its use is strictly regulated, and women of childbearing age must follow strict contraceptive measures.

General data about TALIDOMIDA ACCORD 50mg

  • Substance: thalidomide
  • Date of latest medicines list: 01-06-2026
  • Product code: W67325001
  • Concentration: 50mg
  • Pharmaceutical form: capsules
  • Quantity: 28
  • Product type: Generic medicine
  • Price: 1410.44 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: IDIFARMA DESARROLLO FARMACEUTICO S.L. - SPANIA
  • Holder: ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA
  • Number: 13193/2020/01
  • Shelf life: 2 years

Compensation lists for TALIDOMIDA ACCORD 50mg Accord

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

1410.44 RON

1410.44 RON

0.00 RON